CD4 and hepatocellular carcinoma: In addition, DCs/allo-HCC/sp dual-expressed both WT1 and HLA-DR/CD86 at significantly lower levels than those obtained from DCs/allo-HCC, therefore, could not be optimal for CD4+ and CD8+ T cell stimulation in vitro.